Ultimately, complete loss of central vision may happen. There are two types of macular degeneration, wet and dry. Dry macular degeneration is much more common and happens when the tissue of the ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

Long-term stabilizing of retinal exudation and fluid accumulation contributes to brolucizumab’s efficacy in managing wet age-related macular degeneration (AMD). Visual prognosis could be improved when ...

It is caused by abnormal blood vessel growth (a condition referred to as 'wet' macular degeneration) or atrophy and accumulation of debris ('dry' macular degeneration), both of which damage the ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize ...

It is a good test for screening for the development of "wet" macular degeneration in patients with "dry" macular degeneration.

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age‐related macular degeneration (wet AMD) and diabetic ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina ...

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port ...